Sagent Pharmaceuticals News
Most Popular Sagent Pharmaceuticals Story
Sagent Pharmaceuticals - Biotech IPOs of 2011
Company: Sagent Pharmaceuticals ($SGNT)Based: Schaumburg, ILRaised: $92M (5.75M shares at $16)Target range: $14 to $16Current price: $21.85 Scoop: Sagent Pharmaceuticals is another company whose Read more...
Latest Headlines
- January 17, 2012
- April 6, 2011
- February 28, 2011
- April 8, 2010
- May 21, 2009
- May 9, 2008
- January 28, 2008
- September 27, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
